Reverse Takeover in Israel.
How a private company in Israel can go public in the United States by reverse takeover into a clean Nasdaq, NYSE American or OTC shell — and the home-market considerations that shape the transaction.
Few countries have a stronger track record of taking companies public in the United States than Israel, which hosts one of the largest clusters of Nasdaq-listed businesses anywhere outside America. For an Israeli technology or life-sciences founder, a US listing is not an exotic ambition but a well-worn path that peers, boards, and local advisers already understand. That precedent is exactly why a reverse takeover into a Nasdaq, NYSE American, or OTC shell resonates here: the destination is familiar, and the question is usually about the most efficient route rather than whether US markets are the right home.
- Israel's dense Nasdaq precedent means peers, boards, and local counsel already understand US listings — use that fluency, but confirm current rules.
- Decide early whether the Israeli parent lists directly or a Delaware or Cayman top company is used for the US quote.
- Israeli tax on share exchanges, corporate migration, and employee option pools is a central structuring question for tech issuers.
- PCAOB-registered audit capacity is available locally; still build the timetable around producing SEC-form financials.
- A dual TASE line can be added using US filings, but it adds cost and should be weighed against the benefit.
Israel at a glance
| Home market | Tel Aviv Stock Exchange (TASE) |
|---|---|
| Home regulator | Israel Securities Authority (ISA) |
| Currency | Israeli shekel (ILS) |
| Notable sectors | Technology and cybersecurity, life sciences and medical devices, and clean tech. |
| US venues | Nasdaq, NYSE American, and the OTC Markets (OTCQX, OTCQB) |
| Our role | Advisory and arranger of the reverse takeover; not a broker-dealer, law firm or auditor. |
Why Israel companies list in the United States
Israeli companies gravitate to US markets because that is where their investors, customers, and acquirers already live. Cybersecurity, enterprise software, semiconductors, and medical-device firms are typically built for global — often US-centric — markets from day one, so a US-dollar listing aligns the currency of the shares with the currency of the business. US public markets also offer the deepest pools of specialist technology and biotech capital, richer comparables, and a liquid acquisition currency for the bolt-on M&A many Israeli scale-ups pursue. The density of Israeli names already trading on Nasdaq means analysts, bankers, and index compilers know the ecosystem well. A reverse takeover offers a structured way to reach that base when a conventional IPO window is closed or a faster route is preferred.
The Israel market and a US listing
The Tel Aviv Stock Exchange (TASE) is a capable market, and Israel's regulators have actively encouraged dual TASE/US arrangements — a company reporting under US rules can list in Tel Aviv on the strength of its US filings, easing the burden of maintaining two homes. The comparison, though, is one of depth: TASE liquidity and the breadth of technology-focused institutional coverage are smaller than what a growth company can find on Nasdaq. Many Israeli issuers therefore treat a US quote as the primary listing and a Tel Aviv line as complementary. A reverse takeover can establish the US presence, with a subsequent TASE listing added where a domestic profile is valued.
Sectors driving Israel US listings
Technology and cybersecurity are Israel's calling card, and US investors have shown sustained appetite for Israeli security software, cloud infrastructure, semiconductors, and AI-adjacent businesses. Life sciences and medical devices form a second powerful cluster, supported by strong research institutions and a steady flow of clinical-stage companies that US healthcare specialists actively track. Clean technology and climate-focused innovation add a third strand. Each of these sectors maps directly onto identifiable US public-market investor bases with existing Israeli holdings, which is a large part of why a US reverse takeover is a natural fit for the right Israeli company.
Cross-border structuring from Israel
Cross-border structuring is unusually well-trodden for Israeli companies. Many operate through an Israeli parent that can itself be the US-quoted entity, while others use a Delaware or Cayman top company established for the listing — both patterns are routine, and Israeli and US counsel coordinate them regularly. Israel does not impose the outbound-investment or exchange-control frictions seen in some emerging markets, so moving to a US-quoted structure is generally about corporate, securities, and tax mechanics rather than regulator approvals. Key points to map early include Israeli tax on any share exchange or corporate migration, the treatment of employee option pools (a significant feature of Israeli tech compensation), and Israel Securities Authority (ISA) considerations if a TASE listing is contemplated. This is educational; specific structures should be set with counsel.
Audit and reporting readiness
Audit tends to be less of a bottleneck in Israel than elsewhere, because the ecosystem is already oriented toward US reporting. Israeli growth companies frequently prepare financial statements under US GAAP or IFRS, and the country has deep PCAOB-registered audit capacity through the local offices of global network firms that routinely handle Nasdaq-bound issuers. The critical-path work is therefore less about finding a qualified auditor and more about ensuring the statements, including the comparative periods and any acquired-business accounts, are in the form a reverse takeover filing requires. Even with this head start, the audit timetable should anchor the overall plan rather than be assumed.
Choose a US venue
The same Israel company can target different US venues depending on its size and readiness. Each page below sets out the route and the listing standards.
- Nasdaq listingIsrael → Nasdaq
- NYSE American listingIsrael → NYSE American
- OTC Markets listingIsrael → OTC Markets
Exploring a US listing from Tell us about your company.
Start an enquiry →Reverse Takeover in Israel — frequently asked questions
Q1Why do so many Israeli companies list in the US rather than at home?
Their investors, customers, and acquirers are largely US-based, and US markets offer the deepest technology and biotech capital plus richer comparables. The large existing population of Israeli Nasdaq companies also means the ecosystem is well understood by US analysts and bankers, which lowers the friction of going public there.
Q2Can an Israeli company keep a Tel Aviv listing alongside a US quote?
Yes. Israel's framework lets a company that reports under US rules list on TASE on the strength of its US filings, which reduces duplication. Many issuers treat the US quote as primary and add Tel Aviv for a domestic profile, though the added cost should be weighed with advisers.
Q3Does an Israeli reverse takeover use an Israeli or an offshore parent?
Both patterns are common. Some issuers list the Israeli parent directly; others use a Delaware or Cayman top company created for the listing. Israeli and US counsel coordinate this routinely, and the right choice depends on tax, option-pool treatment, and investor preferences, so it should be set with specialist advice.
Q4Is Reverse Takeover a broker-dealer?
No. Reverse Takeover is an advisory and arranger — not a registered broker-dealer, investment adviser, law firm or audit firm. Regulated work is performed by the US securities counsel, PCAOB-registered auditors and transfer agents we coordinate.
Related markets
This page is general, educational information about listing routes and is not investment, legal, tax, or accounting advice, nor an offer or solicitation. Regulatory details change and vary by circumstance; obtain advice from qualified US securities counsel and your home-market advisers. See our disclosures.